Overview Fundamentals API Earnings EOD API Sample Code Pricing

eFFECTOR Therapeutics Inc (EFTRW PINK) stock market data APIs

$0.0006 0(0%) as of October 16, 2024
Price chart is built with Anychart

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as completed Phase 2a open-label expansion cohort in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. The company has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E; and collaboration agreement with the Dana-Farber Cancer Institute on a Phase 2 clinical trial, evaluating Zotatifin as combination treatment in ER+ endometrial cancer and in low grade serous ovarian cancer. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.

eFFECTOR Therapeutics Inc Financial Data Overview

0.0006
0.0006
-
0.0006
0.0006
0.0003-0.1875
0
0
675 K
0.4242
0.8
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EFTRW',
Type: 'Common Stock',
Name: 'eFFECTOR Therapeutics Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YMYC7F1',
ISIN: NULL,
CUSIP: NULL,
CIK: '1828522',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-03-01',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Warrant',
IsDelisted: false,
}

eFFECTOR Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 675 K
  • EBITDA -32 593 000
  • Earnings Per Share -0.905
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get eFFECTOR Therapeutics Inc Earnings via APIs

  • Latest Release 2021-09-30
  • EPS/Forecast 0

Get eFFECTOR Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com